-
-
-
-
-
-
-
Theravance Biopharma Reports Phase 3 CYPRESS Study Did Not Meet Primary Endpoint; Board Accelerates Strategic Review and Announces Cost Reduction Actions
-
-
-
-
-
-
-
Theravance Biopharma, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Theravance Biopharma to Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025
-
-
-
-
-
-
-
Theravance Biopharma to Report Second Quarter 2024 Financial Results on August 5, 2024
-
-
-
-
-
-
-
Theravance Biopharma (TBPH) Tops Q3 EPS by 4c
-
-
-
-
-
-
-
Theravance Biopharma, Inc. Reports First Quarter 2023 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Theravance Biopharma, Inc. Reports Third Quarter 2022 Financial Results, Provides Business Update and Extends Tender Offer
-
1,204,707 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

